Renal Disease Treatments Technology Market By Treatment Procedures (Hemodialysis Dialyzer, Kidney Transplant), Types Of Devices (Devices For Urinary Stone Treatment, Dialysis, Devices For Endoscopy, Pelvic Organ Prolapsed Treatment, Benign Prostatic Hyperplasia Treatment Devices, Devices For Pelvic Organ Prolapsed Treatment, Vaginal Meshes & Slings, Catheter Ablation And Urinary Stone Treatment), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: May 25, 2016

Key Findings

 

The global renal disease treatments technology market is expected to grow at the CAGR of 6.8% during 2015-2022, and is expected to reach the $86 billion mark by 2022. The global renal disease treatment market is expected to grow at a rapid pace due to rising incidences of chronic kidney diseases and end stage renal diseases. Rising lifestyle associated diseases and rising patient’s base of hypertension are the two major reasons behind kidney related diseases that are expected to drive the demand of global renal diseases treatment technology market during the forecast year. Increasing geriatric population base is also one of the major factor. The kidney related diseases and problems are mainly faced by the people having diabetes and high blood pressure. The rising rate of renal diseases has shifted doctor’s preferences towards the use of advanced renal diseases treatment technology to reduce treatment and recovery time. The global players find the market a high-revenue generating market, and are investing in medical treatment devices and other technological advanced surgical procedure that can minimize the time for kidney treatment. Increasing lifestyle associated diseases also plays an important role in boosting up global renal disease treatment market, as due to changes in lifestyle people are expected to get more diabetic problems, blood pressure problem and these two increases the renal disease very rapidly. As per a survey by WHO, more than one-third of kidney related issues are happening to those who is having diabetes or high blood pressure related problems. This type of lifestyle related problems also enhances the global renal disease treatment market.

 

Market Segment Insights

 

The market is majorly segmented into treatment procedures, types of devices, and regional outlook. In treatment procedure, market is divided into hemodialysis dialyzer and kidney transplant. Hemodialysis dialyzer accounts for one of the largest market share owing to its extensive usage by chronic kidney diseases patients, and it is safer than kidney transplant. In types of devices, market is segmented into devices for urinary stone treatment, dialysis, devices for endoscopy, devices for pelvic organ prolapsed treatment, benign prostatic hyperplasia treatment devices, devices for pelvic organ prolapsed treatment, vaginal meshes & slings, catheter ablation and urinary stone treatment. Dialysis segment held the largest market share as it is cheap in cost as compare to other devices and is very common in chronic renal diseases patients. In terms of geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. In global renal disease treatment technology market, North America is contributing the largest revenue, due to presence of supportive government policies, sophisticated healthcare facility, and high number of kidney patients. The U.S and Canada are the two major countries in North America contributing to the market. Europe is also one of biggest and fast growing market and is expected to grow further in the near future. The Asia-Pacific is the fastest growing renal diseases treatment technology market due to rise in the geriatric population and prevalence of chronic diseases among people. Rest of the world contributes very low in this market.

 

Regional Insights

 

The Global renal disease treatment market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America is the major player in global renal disease treatments technology market, and the major reason in rise of the market is technological advancement in medical field, increasing adoption of technologically advance devices, especially, in the hospitals, and high quality of infrastructure is fueling the renal disease treatment market in North America, where the U.S and Canada are the two major players, as they have technological advancement and increasing amount of disposable income per individual. Asia pacific is the fastest growing renal disease treatment technology market due to rise in aged population. In Asia-Pacific, India and China are the major countries that holds the major share in the global renal disease treatment market. Europe is also one of the biggest market of renal disease treatment, and the main reason that drives the European market is advancement in surgical procedure in hospitals due to technological advancement, rise in aging population and government’s policies that helps to build the renal disease treatment market. Rest of the world is having the least market share in global renal disease treatment market due to lack of advancement in the field of medical science.

 

Competitive Insights

 

Some of the key market players are Asahi Kasei Medical Co. Ltd, Baxter International Inc., Bayer healthcare, Cerulean Pharma, Davita Kidney Care, Exelixis, Pfizer, Roche, and Novartis etc. Acquisitions, new product development, collaborations, joint ventures, mergers and expansions are the key strategies adopted by the market players to sustain in the market. Bayer and BioNTech join forces to develop innovative products in near future.

CHAP 1. METHODOLOGY & SCOPE 13
    1.1. RESEARCH METHODOLOGY 13
    1.2. RESEARCH SCOPE & ASSUMPTIONS 13
    1.3. LIST OF DATA SOURCES 13

 

CHAP 2. EXECUTIVE SUMMARY 14
    2.1. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET SUMMARY & KEY BUYING CRITERIA 14
    2.2. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET OUTLOOK 14
    2.3. MARKET SEGMENTATION ANALYSIS 14
    2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 14
    2.5. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET VALUE CHAIN ANALYSIS 14
    2.6. VENDOR LANDSCAPE 14

 

CHAP 3. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET 15
    3.1. MARKET DRIVER ANALYSIS 15
        3.1.1. INCREASING NUMBER OF LIFESTYLE ASSOCIATED DISEASES 15
        3.1.2. RISING NUMBER OF CHRONIC KIDNEY DISEASES 15
        3.1.3. RISING HEALTHCARE INDUSTRY AND MEDICAL SPENDING 15
    3.2. MARKET RESTRAINT ANALYSIS 15
        3.2.1. LACK OF PROPER TRAETMENT IN UNDERDEVELOPED COUNTRIES 15
        3.2.2. LACK OF SKILLED AND TRAINED PROFESSIONALS 15
    3.3. KEY OPPORTUNITIES 15
        3.3.1. TECHNOLOGICAL ADVANCEMENT IN THE FIELD OF RENAL DISEASES 15
        3.3.2. INCREASING GERIATRIC POPULATION 15
    3.4. CHALLENGES 15
        3.4.1. HIGH TREATMENT COSTS 15
        3.4.2. TECHNOLOGICAL ADVANCEMENT ENHANCES THE SURGICAL PROCEDURES 15

 

CHAP 4. INDUSTRY ANALYSIS 16
    4.1. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET – PORTER’S FIVE FORCE MODEL 16
    4.2. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET – PESTEL ANALYSIS 16
    4.3. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET – GAP ANALYSIS 16

 

CHAP 5. GLOBAL RENAL DISEASES TREATMENT TECHNOLOGY MARKET BY TREATMENT PROCEDURES 2012-2022 ($ BILLION) 17
    5.1. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY HEMODIALYSIS DIALYZER 2012-2022 ($ BILLION) 17
    5.2. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY KIDNEY TRANSPLANT 2012-2022 ($ BILLION) 17

 

CHAP 6. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY TYPES OF DEVICES 2012-2022 ($ BILLION) 18
    6.1. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY DEVICES FOR URINARY STONE TREATMENT 2012-2022 ($ BILLION) 18
    6.2. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY DIALYSIS 2012-2022 ($ BILLION) 18
    6.3. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY DEVICES FOR ENDOSCOPY 2012-2022 ($ BILLION) 18
    6.4. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY DEVICES FOR PELVIC ORGAN PROLAPSED TREATMENT 2012-2022 ($ BILLION) 18
    6.5. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICES 2012-2022 ($ BILLION) 18
    6.6. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY DEVICES FOR PELVIC ORGAN PROLAPSED TREATMENT 2012-2022 ($ BILLION) 18
    6.7. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY VAGINAL MESHES & SLINGS 2012-2022 ($ BILLION) 18
    6.8. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY CATHETER ABLATION AND URINARY STONE TREATMENT 2012-2022 ($ BILLION) 18

 

CHAP 7. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET REGIONAL OUTLOOK 2012-2022 ($ BILLION) 19
    7.1. GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY REGION 2012-2022 ($ BILLION) 19
    7.2. NORTH AMERICA 19
        7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
        7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 19
        7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
            7.2.3.1. U.S. 19
                7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
                7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
            7.2.3.2. CANADA 19
                7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
                7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
    7.3. EUROPE 20
        7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
        7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 20
        7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
            7.3.3.1. GERMANY 20
                7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
                7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
            7.3.3.2. UK 20
                7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
                7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
            7.3.3.3. FRANCE 20
                7.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
                7.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
            7.3.3.4. ITALY 20
                7.3.3.4.1. ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
                7.3.3.4.2. ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
            7.3.3.5. SPAIN 20
                7.3.3.5.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
                7.3.3.5.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
            7.3.3.6. REST OF EUROPE 21
                7.3.3.6.1. REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ BILLION) 21
                7.3.3.6.2. REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
    7.4. ASIA PACIFIC 21
        7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
        7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 21
        7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
            7.4.3.1. CHINA 21
                7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
                7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
            7.4.3.2. INDIA 21
                7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
                7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
            7.4.3.3. JAPAN 21
                7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
                7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
            7.4.3.4. SOUTH KOREA 21
                7.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
                7.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
            7.4.3.5. REST OF APAC 22
                7.4.3.5.1. REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
                7.4.3.5.2. REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
    7.5. REST OF THE WORLD 22
        7.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
        7.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 22
        7.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
            7.5.3.1. LATIN AMERICA 22
                7.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
                7.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
            7.5.3.2. MIDDLE EAST AND AFRICA 22
                7.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
                7.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22

CHAP 8. COMPETITIVE LANDSCAPE 23
    8.1. ASAHI KASEI MEDICAL CO., LTD. 24
        8.1.1. COMPANY OVERVIEW 24
        8.1.2. SCOT ANALYSIS 24
        8.1.3. PRODUCT BENCHMARKING 24
        8.1.4. STRATEGIC INITIATIVES 24
    8.2. BAXTER INTERNATIONAL INC. 24
        8.2.1. COMPANY OVERVIEW 24
        8.2.2. SCOT ANALYSIS 24
        8.2.3. PRODUCT BENCHMARKING 24
        8.2.4. STRATEGIC INITIATIVES 24
    8.3. BAYER HEALTHCARE 24
        8.3.1. COMPANY OVERVIEW 24
        8.3.2. SCOT ANALYSIS 24
        8.3.3. PRODUCT BENCHMARKING 24
        8.3.4. STRATEGIC INITIATIVES 24
    8.4. BRISTOL-MYERS SQUIBB 24
        8.4.1. SCOT ANALYSIS 24
        8.4.2. PRODUCT BENCHMARKING 24
        8.4.3. STRATEGIC INITIATIVES 24
    8.5. CERULEAN PHARMA 24
        8.5.1. COMPANY OVERVIEW 24
        8.5.2. SCOT ANALYSIS 24
        8.5.3. PRODUCT BENCHMARKING 24
        8.5.4. STRATEGIC INITIATIVES 24
    8.6. DAVITA KIDNEY CARE 24
        8.6.1. COMPANY OVERVIEW 24
        8.6.2. SCOT ANALYSIS 24
        8.6.3. PRODUCT BENCHMARKING 25
        8.6.4. STRATEGIC INITIATIVES 25
    8.7. EXELIXIS 25
        8.7.1. COMPANY OVERVIEW 25
        8.7.2. SCOT ANALYSIS 25
        8.7.3. PRODUCT BENCHMARKING 25
        8.7.4. STRATEGIC INITIATIVES 25
    8.8. MEDICAL COMPONENTS, INC. 25
        8.8.1. COMPANY OVERVIEW 25
        8.8.2. SCOT ANALYSIS 25
        8.8.3. PRODUCT BENCHMARKING 25
        8.8.4. STRATEGIC INITIATIVES 25
    8.9. MEDIVATORS, INC. 25
        8.9.1. COMPANY OVERVIEW 25
        8.9.2. SCOT ANALYSIS 25
        8.9.3. PRODUCT BENCHMARKING 25
        8.9.4. STRATEGIC INITIATIVES 25
    8.10. MERCK & CO. GMBH 25
        8.10.1. COMPANY OVERVIEW 25
        8.10.2. SCOT ANALYSIS 25
        8.10.3. PRODUCT BENCHMARKING 25
        8.10.4. STRATEGIC INITIATIVES 25
    8.11. NIPRO DIAGNOSTICS INC. 25
        8.11.1. COMPANY OVERVIEW 25
        8.11.2. SCOT ANALYSIS 25
        8.11.3. PRODUCT BENCHMARKING 25
        8.11.4. STRATEGIC INITIATIVES 25
    8.12. NOVARTIS 26
        8.12.1. COMPANY OVERVIEW 26
        8.12.2. SCOT ANALYSIS 26
        8.12.3. PRODUCT BENCHMARKING 26
        8.12.4. STRATEGIC INITIATIVES 26
    8.13. PFIZER 26
        8.13.1. COMPANY OVERVIEW 26
        8.13.2. SCOT ANALYSIS 26
        8.13.3. PRODUCT BENCHMARKING 26
        8.13.4. STRATEGIC INITIATIVES 26
    8.14. ROCHE 26
        8.14.1. COMPANY OVERVIEW 26
        8.14.2. SCOT ANALYSIS 26
        8.14.3. PRODUCT BENCHMARKING 26
        8.14.4. STRATEGIC INITIATIVES 26
    8.15. ROCKWELL MEDICAL TECHNOLOGIES INC. 26
        8.15.1. COMPANY OVERVIEW 26
        8.15.2. SCOT ANALYSIS 26
        8.15.3. PRODUCT BENCHMARKING 26
        8.15.4. STRATEGIC INITIATIVES 26

TABLE 1 GLOBAL RENAL DISEASES TREATMENT TECHNOLOGY MARKET BY TREATMENT PROCEDURES 2012-2022 ($ BILLION) 26
TABLE 2 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY HEMODIALYSIS DIALYZER 2012-2022 ($ BILLION) 26
TABLE 3 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY KIDNEY TRANSPLANT 2012-2022 ($ BILLION) 26
TABLE 4 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY TYPES OF DEVICES 2012-2022 ($ BILLION) 27
TABLE 5 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY DEVICES FOR URINARY STONE TREATMENT 2012-2022 ($ BILLION) 27
TABLE 6 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY DIALYSIS 2012-2022 ($ BILLION) 27
TABLE 7 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY DEVICES FOR ENDOSCOPY 2012-2022 ($ BILLION) 27
TABLE 8 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY DEVICES FOR PELVIC ORGAN PROLAPSED TREATMENT 2012-2022 ($ BILLION) 27
TABLE 9 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICES 2012-2022 ($ BILLION) 27
TABLE 10 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY DEVICES FOR PELVIC ORGAN PROLAPSED TREATMENT, 2012-2022 ($ BILLION) 27
TABLE 11 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY VAGINAL MESHES & SLINGS 2012-2022 ($ BILLION) 27
TABLE 12 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY CATHETER ABLATION AND URINARY STONE TREATMENT 2012-2022 ($ BILLION) 27
TABLE 13 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET REGIONAL OUTLOOK 2012-2022 ($ BILLION) 27
TABLE 14 GLOBAL RENAL DISEASE TREATMENT TECHNOLOGY MARKET BY REGION 2012-2022 ($ BILLION) 27
TABLE 15 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
TABLE 16 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 27
TABLE 17 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 27
TABLE 18 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
TABLE 19 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 20 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 21 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 22 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 23 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 28
TABLE 24 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 25 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 26 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 27 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 28 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 29 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 30 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 31 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 32 ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 33 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
TABLE 34 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 28
TABLE 35 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 28
TABLE 36 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 37 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 38 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 29
TABLE 39 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 40 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 41 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 42 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 43 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 44 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 45 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 46 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 47 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 48 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 49 REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 50 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
TABLE 51 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 29
TABLE 52 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 29
TABLE 53 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
TABLE 54 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 30
TABLE 55 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
TABLE 56 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 30

FIGURE 1 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 2 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 8 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 10 REST OF EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 11 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 15 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 16 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 17 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 18 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31
FIGURE 19 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 31

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)